Trinutra Ltd.

N.s. Oils Ltd.

Mor Zeilkha

Yoram Sela

Itschak Lamensdorf

Dani Rapaport

Rotem Albert

Gidon Albert

The invention provides a composition comprising oil obtained fromseeds and one or more surface-active agents. Preferably, the concentration of thymoquinone in the composition is at least 2% (w/w), wherein the concentration of the surface-active agent(s) is at least 0.2% (w/w), and wherein the one or more surface-active agents are selected from the group consisting of D-α-Tocopherol polyethylene glycol succinate (TPGS), lecithin and isolecithin. The invention also provides a method for preventing and/or treating pathological states and disorders associated with obesity, comprising the steps of administering a composition of the invention to a human subject.

Composition comprisingoil and surface-active agents

The present invention is directed to composition comprising(NS) oil, wherein said oil comprises thymoquinone (TQ) at a concentration of at least 2% (w/w). The composition is further characterized by having a much lower free fatty acid concentration than prior art compositions. The composition, which has anti-inflammatory activity, may be formulated for oral administration to a mammalian subject, for the purpose of preventing or treating inflammatory conditions and other disorders.

oil composition

The present invention provides a composition comprising a synergistic combination of thymoquinone and one or more omega-3 fatty acids, wherein the molar ratio between said thymoquinone and said one or more omega-3 fatty acids is at least 1:7. The present invention also provides a method of using said composition to treat or prevent inflammatory conditions.

Compositions comprising thymoquinone and omega-3 fatty acids

The present invention provides a therapeutic composition comprising a synergistic combination of caffeine,, and &#x3b2;-phenylethylamine (PEA) or its salt. The invention is also directed to oral dosage forms containing said composition, and to a method of treatment of a psychological, psychiatric, behavioral and/or neurodevelopmental disorder comprising the administration of said compositions and dosage forms to a patient in need thereof.

Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamine

The present invention provides a composition comprising a synergistic combination of melatonin, valerenic acid and carnosic acid. The composition may be used in the treatment and prevention of several different disorders including inflammatory conditions, sleep disorders and anxiety. The invention also relates to several dosage forms which are suitable for the delivery of the claimed composition to subjects in need of treatment therewith.

Growing community of inventors

Ramat Gan, Israel

Mor Zeilkha